Compound Evidence File
#EC-2026-0986
Nandrolone Decanoate (Deca) Raw
Filed under Raw Materials. The bureau holds 133 laboratory returns for this compound from 46 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
46 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Feb 2026 | 2 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 27 Jan 2026 | 25 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Apr 2026 | 13 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 7 Jan 2026 | 24 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Feb 2026 | 24 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 10.0 | 10.0 | 10.0 | 13 Feb 2026 | 14 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 7 May 2026 | 11 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 15 Nov 2025 | 10 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Jan 2026 | 2 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 10 Mar 2026 | 7 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 16 Jan 2026 | 11 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 21 Jan 2026 | 13 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 8 Jan 2026 | 18 Apr 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 10.0 | 3 Feb 2026 | 12 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 27 Jan 2026 | 9 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 26 Feb 2026 | 15 Mar 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Jan 2026 | 7 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Feb 2026 | 10 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 9.9 | 16 May 2026 | 27 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 9.9 | 4 Jun 2026 | 8 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 9 Feb 2026 | 14 Mar 2026 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 9.0 | 9.0 | 9.0 | 21 May 2025 | 21 May 2025 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.9 | 8.9 | 8.9 | 9 Jun 2025 | 9 Jun 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 8.8 | 8.8 | 8.8 | 3 Jun 2025 | 3 Jun 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.7 | 8.0 | 9.7 | 25 May 2026 | 25 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.5 | 6.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.5 | 6.7 | 9.4 | 24 May 2026 | 24 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 8.5 | 8.5 | 8.5 | 17 Dec 2024 | 17 Dec 2024 |
| UtherCASE #VI-2026-0902 | X | 2 | 8.4 | 8.4 | 8.4 | 14 Jan 2025 | 23 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.2 | 6.4 | 9.2 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.1 | 7.1 | 9.3 | 24 May 2026 | 24 May 2026 |
| PeptiSlimCASE #VI-2026-0557 | X | 2 | 7.6 | 6.2 | 8.9 | 11 Jun 2025 | 21 May 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 7.6 | 7.6 | 7.6 | 7 May 2025 | 7 May 2025 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 7.5 | 7.5 | 7.5 | 3 Jul 2025 | 3 Jul 2025 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 7.5 | 7.5 | 7.5 | 25 Apr 2025 | 25 Apr 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 7.4 | 7.4 | 7.4 | 20 Jun 2025 | 20 Jun 2025 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 7.4 | 7.4 | 7.4 | 21 May 2025 | 21 May 2025 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 7.3 | 7.0 | 7.7 | 2 Apr 2025 | 19 Jan 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 1 | 6.4 | 6.4 | 6.4 | 3 Jun 2025 | 3 Jun 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 4 | 6.3 | 5.3 | 7.0 | 3 Jul 2025 | 23 May 2026 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 6.1 | 6.1 | 6.1 | 13 Jun 2025 | 13 Jun 2025 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 5.5 | 5.5 | 5.5 | 14 Jan 2025 | 14 Jan 2025 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 4.2 | 4.2 | 4.2 | 6 May 2025 | 6 May 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for Nandrolone Decanoate (Deca) Raw alone.